Hari Subramaniam is a Managing Partner at Subramaniam & Associates. Hari Subramaniam is an Attorney-at-Law and a Registered Patent Agent with a background in physics, chemistry, biological and life sciences, and medicine. He is the Managing Partner of Subramaniam & Associates, a leading IP boutique firm founded in 1998, and has been in practice for the last 40 years, specializing in all aspects of intellectual property laws.

In the course of his career, Mr. Subramaniam has filed, prosecuted, defended, opposed and/or enforced - directly or in a supervisory capacity - over 45,000 patent matters in India and abroad, relating to all areas of technology. He was the first person to initiate black-box (mailbox) applications for pharmaceutical products in India under the GATT/TRIPS Agreement, which formed the basis for subsequent amendments to the Indian Patents Act. He has advised the Governments of India, Mauritius, Bangladesh, China and Nepal on their IP laws. He has been called upon several times as an expert witness before the Joint Parliamentary Committee for the amendment of patent laws in India.

Mr. Subramaniam is the longest serving Council Member from India in the Asian Patent Attorneys Association (APAA), and has spearheaded the Patent Committee of the Indian Group on the APAA Standing Committee on 4 different occasions over 2 decades. He has served as International Vice-President of APAA for several years, and is also part of the Advisory Council of APAA International. In addition, he is part of the Workshop Committee of APAA International, and was co-Chair of the Organising Committee for the APAA Council Meetings in 2005 and 2018, attended by delegates from over 65 countries. He is the only person to have been elected President of the APAA India Chapter twice.

Mr. Subramaniam is regularly invited as faculty or speaker at several seminars and conferences and patent awareness workshops conducted by the Government of India, World Intellectual Property Organisation (WIPO), the American Bar Association, the Minneapolis Bar Association, the Indian Patent Office, patent offices and universities across the world, and international organisations such as APAA and the Association Internationale pour la Protection de la Propriété Intellectuelle (AIPPI). He has been on the Pharma and Biotech Committees of AIPPI for many years and has been invited a number of times as a speaker at AIPPI Pharma workshops. He has authored several papers relating to key aspects of intellectual property laws, as well as chapters on the Indian jurisdiction for leading global publications and books which are featured in the libraries of premier law colleges and Ivy League universities.